Weekly administration of sagopilone (ZK-EPO), a fully synthetic epothilone, in patients with refractory solid tumours: results of a phase I trial

被引：0
|
作者：
D Arnold
W Voigt
P Kiewe
C Behrmann
S Lindemann
S Reif
H Wiesinger
M Giurescu
E Thiel
H-J Schmoll
机构：
[1] Martin Luther University,Department of Hematology and Oncology
[2] Oncology and Transfusion Medicine,Department of Hematology
[3] Charité Campus Benjamin Franklin,Department of Radiology
[4] Martin Luther University,undefined
[5] Bayer Schering Pharma AG,undefined
[6] Global Medical Development Oncology,undefined
[7] Bayer Schering Pharma AG,undefined
来源：
British Journal of Cancer | 2009年 / 101卷
关键词：
dose-limiting toxicity; epothilone; maximum tolerated dose; phase I; refractory solid tumours; sagopilone;
D O I：
暂无
中图分类号：
学科分类号：
摘要：
引用
收藏
页码：1241 / 1247
页数：6
相关论文
共 50 条
  • [21] PHASE I/II STUDY OF SAGOPILONE (ZK-EPO) PLUS CARBOPLATIN IN WOMEN WITH RECURRENT PLATINUM-SENSITIVE OVARIAN CANCER
    McMeekin, S.
    Patel, R.
    Verschraegen, C.
    Celano, P.
    Burke, J.
    Plaxe, S.
    Ghatage, P.
    Giurescu, M.
    Stredder, C.
    Wang, Y.
    ANNALS OF ONCOLOGY, 2008, 19 : 211 - 211
  • [22] First clinical pharmacokinetic dose-escalation study of sagopilone, a novel, fully synthetic epothilone, in Japanese patients with refractory solid tumors
    Araki, Kazuhiro
    Kitagawa, Koichi
    Mukai, Hirofumi
    Mukohara, Toru
    Kodama, Keiji
    Ando, Yuichi
    Narabayashi, Masaru
    Minami, Hironobu
    Mera, Kiyomi
    Sasaki, Yasutsuna
    INVESTIGATIONAL NEW DRUGS, 2012, 30 (06) : 2327 - 2333
  • [23] First clinical pharmacokinetic dose-escalation study of sagopilone, a novel, fully synthetic epothilone, in Japanese patients with refractory solid tumors
    Kazuhiro Araki
    Koichi Kitagawa
    Hirofumi Mukai
    Toru Mukohara
    Keiji Kodama
    Yuichi Ando
    Masaru Narabayashi
    Hironobu Minami
    Kiyomi Mera
    Yasutsuna Sasaki
    Investigational New Drugs, 2012, 30 : 2327 - 2333
  • [24] Phase II study evaluating the efficacy and safety of sagopilone (ZK-EPO) in patients with metastatic breast cancer that has progressed following chemotherapy
    Morrow, Phuong K.
    Divers, Stephen
    Provencher, Louise
    Luoh, Shiuh-Wen
    Petrella, Teresa M.
    Giurescu, Marius
    Schmelter, Thomas
    Wang, Yao
    Hortobagyi, Gabriel N.
    Vahdat, Linda T.
    BREAST CANCER RESEARCH AND TREATMENT, 2010, 123 (03) : 837 - 842
  • [25] Sagopilone (ZK-EPO, ZK 219477) for recurrent glioblastoma. A phase II multicenter trial by the European Organisation for Research and Treatment of Cancer (EORTC) Brain Tumor Group
    Stupp, R.
    Tosoni, A.
    Bromberg, J. E. C.
    Hau, P.
    Campone, M.
    Gijtenbeek, J.
    Frenay, M.
    Breimer, L.
    Wiesinger, H.
    Allgeier, A.
    van den Bent, M. J.
    Bogdahn, U.
    van der Graaf, W.
    Yun, H. J.
    Gorlia, T.
    Lacombe, D.
    Brandes, A. A.
    ANNALS OF ONCOLOGY, 2011, 22 (09) : 2144 - 2149
  • [26] Phase II study evaluating the efficacy and safety of sagopilone (ZK-EPO) in patients with metastatic breast cancer that has progressed following chemotherapy
    Phuong K. Morrow
    Stephen Divers
    Louise Provencher
    Shiuh-Wen Luoh
    Teresa M. Petrella
    Marius Giurescu
    Thomas Schmelter
    Yao Wang
    Gabriel N. Hortobagyi
    Linda T. Vahdat
    Breast Cancer Research and Treatment, 2010, 123 : 837 - 842
  • [27] Phase I study of sagopilone (ZK-EPO) in combination with cisplatin in patients with chemotherapy-naive extensive disease small-cell lung cancer (ED-SCLC)
    Gauler, Thomas C.
    Christoph, Daniel
    Gamarra, Fernando
    Fuhr, Heinz-Georg
    Fischer, Juergen R.
    Gonschorek, Christine
    Giurescu, Marius
    Frickhofen, Norbert
    Huber, Rudolf M.
    Schuler, Martin
    Eberhardt, Wilfried E.
    JOURNAL OF THORACIC ONCOLOGY, 2009, 4 (09) : S467 - S467
  • [28] A phase I clinical and pharmacokinetic study of EPO906 (epothilone B) in patients with advanced solid tumours.
    Calvert, PM
    O'Neill, V
    Azzabi, A
    Hughes, A
    Plummer, R
    Twelves, C
    Robinson, A
    Machan, MA
    Dimitrijevic, S
    Moss, D
    Rothermel, J
    Cohen, P
    Chen, T
    Man, A
    Calvert, AH
    CLINICAL CANCER RESEARCH, 2000, 6 : 4581S - 4581S
  • [29] Weekly administration of bendamustine:: A phase I study in patients with advanced progressive solid tumours
    Schöffski, P
    Seeland, G
    Engel, H
    Grünwald, V
    Paul, H
    Merkle, K
    Kowalski, R
    Ganser, A
    ANNALS OF ONCOLOGY, 2000, 11 (06) : 729 - 734
  • [30] PHASE I STUDY OF SAGOPILONE (ZK-EPO) IN COMBINATION WITH CISPLATIN IN PATIENTS WITH CHEMOTHERAPY-NAIVE EXTENSIVE-DISEASE SMALL-CELL LUNG CANCER (ED-SCLC)
    Gauler, T. C.
    Christoph, D.
    Gamarra, F.
    Fuhr, H. G.
    Gonschorek, C.
    Giurescu, M.
    Frickhofen, N.
    Huber, R. M.
    Schuler, M.
    Eberhardt, W.
    ANNALS OF ONCOLOGY, 2008, 19 : 118 - 118
12345